Michael Valente

The activation trajectory of plasmacytoid dendritic cells in vivo during a viral infection

Abdenour Abbas, Thien‐Phong Vu Manh, Michael Valente et al. · Nature Immunology · 2020 · 92 citations · Full text

Plasmacytoid Dendritic Cells, Activation Trajectory, Immunology +7

Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses

Yusuf Dölen, Michael Valente, Oya Tagit et al. · OncoImmunology · 2020 · 56 citations · Full text

Immunology, Biological Therapy, Immunotherapeutics +21

TCR Signaling Events Are Required for Maintaining CD4 Regulatory T Cell Numbers and Suppressive Capacities in the Periphery

Arnaud Delpoux, Philippe Yakonowsky, Aurélie Durand et al. · The Journal of Immunology · 2014 · 43 citations

Endolysosomal‐Escape Nanovaccines through Adjuvant‐Induced Tumor Antigen Assembly for Enhanced Effector CD8⁺ T Cell Activation

Liping Qiu, Michael Valente, Yusuf Dölen et al. · Small · 2018 · 40 citations · Full text

PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses

Yusuf Dölen, Uzi Gileadi, Ji‐Li Chen et al. · Frontiers in Immunology · 2021 · 36 citations · Full text